Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1969 Jul 1;130(1):185-202.
doi: 10.1084/jem.130.1.185.

Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid

Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid

R A Finkelstein et al. J Exp Med. .

Abstract

Choleragen, a diarrheagenic protein enterotoxin elaborated by Vibrio cholerae, has been isolated from the supernate of fermenter cultures by steps involving ammonium sulfate precipitation, DEAE cellulose, Sephadex G-75, and Agarose A-5m chromatography. The resulting product appears to be pure according to immunoelectrophoretic, disc electrophoretic, ultracentrifugal, and immunologic criteria. Sephadex gel filtration and membrane filtration studies suggest a molecular size of 61,000. The isolated product is highly active in inducing experimental cholera in infant and adult rabbit models. It also elicits, in small dosage, an increased vascular permeability in skin. These observations indicate that choleragenicity and increased vascular permeability are intimately associated phenomena and may be manifestations of the same basic mechanism. An additional, antigenically identical, protein has also been isolated by the same procedures. The latter substance, termed "choleragenoid", lacks the permeability effect and choleragenicity of the choleragen moiety. Its size (estimated from Sephadex gel filtration at 42,000) is smaller than that of choleragen and it also differs in charge. Choleragenoid may prove useful as a nontoxic immunogen to protect against pathologic effects of V. cholerae infection.

PubMed Disclaimer

References

    1. Br Med J. 1966 Jan 15;1(5480):140-2 - PubMed
    1. Biochem J. 1965 Sep;96(3):595-606 - PubMed
    1. J Immunol. 1966 Mar;96(3):440-9 - PubMed
    1. Nature. 1965 Aug 7;207(997):614-6 - PubMed
    1. J Immunol. 1966 Jul;97(1):25-33 - PubMed